Login

Antony Mattessich, President & CEO, Ocular Therapeutix 00:00:00

Share On Facebook Share On Twitter

Ocular Therapeutix

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Phil Bolan Discusses Financial Wellness Month and Budgeting Tips
00:10:00
Bitcoin is 'anti-fragile Pomp Investments but hing end up down rate|Anthony Pompliano,Angel Investor,Pomp Investments
00:10:00
the world’s most extraordinary people who are building companies|Mercedes Bent,Partner,Lightspeed Venture Partners
00:10:00
David Epstein on Why Generalists Succeed, the Value of Diversity, and Unconventional Thinking with Nicolai Tangen
00:10:00
The Bargainer: Shelby Steele on Race and American Identity|Shelby Steele
00:10:00
OceanPact CEO Flavio Nogueira Pinheiro Discusses Strategy to Secure More Contracts and Boost Profits | Flavio Nogueira Pinheiro ,CEO, OceanPact Serviços Marítimos S.A.
00:10:00
A year ago, VTEX Co-Founder and Co-CEO Mariano Gomide de Faria discussed the growth of conversational commerce.|Gomide de Faria is our Founder and Co-Chief Executive Officer,
00:10:00
Tom Lydon interviews David Mazza, Head of ETF Investment Strategy at State Street Global Advisors, exploring insights into ETF investment strategies.|Yie-Hsin Hung is president and chief executive officer of State Street Global Advisors
00:00:00
CEO Michiel Langezaal is excited about his EV-inspired moment. | MICHIEL LANGEZAAL, CEO AT FASTNED BV
00:10:00
Guy Hands on Brexit's Impact: U.K. Exports, Investment Strategy, and ESG in M&A | Guy Hands, Chairman, Terra Firma Capital Partners.
00:10:00
Simon Linge, CEO of hipages Group Holdings Pty Ltd, presents at the ASX Small and Mid-Cap Conference in March 2024.
00:10:00
Focus on investing in tech companies|Gayle Jennings O'Byrne, General Partner,WOCstar Fund

© 2017 - Neuhu+